Finance

Roʻyxatlar
Nega RVTY tushdi 4,25%?
Batafsil oʻrganish
RVTY:NYSE
Revvity Inc
145,22 US$
-4,25%
(-6,45) 1K
145,10 US$
-0,08% (-0,12)
Yopilgandan keyin
Savdolar yopilgan: 20-noy, 16:00:03 (GMT-5)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
RVTY tikeri uchun statistika yaratilmoqda...
Ochish
150,93 US$
Yuqori
150,93 US$
Past
143,61 US$
Bozor kapitali
16,21 mlrd
Oʻrtacha hajm
1,73 mln
Hajmi
1,66 mln
52 haftalik eng yuqori
171,74 US$
52 haftalik eng past
81,22 US$
Beta
1,08
Muomaladagi aksiyalar
111,64 mln
Xodimlar soni
11 ming
Ochish
150,93 US$
Yuqori
150,93 US$
Past
143,61 US$
Bozor kapitali
16,21 mlrd
Oʻrtacha hajm
1,73 mln
Hajmi
1,66 mln
52 haftalik eng yuqori
171,74 US$
52 haftalik eng past
81,22 US$
Beta
1,08
Muomaladagi aksiyalar
111,64 mln
Xodimlar soni
11 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Revvity Inc haqida
CEOPrahlad Singh
Xodimlar soni11 ming
Asos solingan1947
Bosh ofislarWaltham, Massachusetts, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytrevvity.com
Analitik reytinglar
Oxirgi 3 oyda RVTY aksiyalari boʻyicha reyting bergan 15 tahlilchi xulosasiga koʻra
Sotib olish
Sotib olish
6
Ushlab qolish
9
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda RVTY uchun 12 oylik narx maqsadlarini taklif qilgan 15 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 145,22 US$
200,00 US$ (+37,72%)
O‘rtacha
173,00 US$ (+19,13%)
Eng past
140,00 US$ (-3,59%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Eve Burstein
Bernstein
Hold
Maintained
160,00 US$
+10,2%
11/18/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
177,00 US$
+21,9%
11/16/2026
Puneet Souda
Leerink Partners
Buy
Reiterated
180,00 US$
+23,9%
11/16/2026
Casey Woodring
J.P. Morgan
Hold
Reiterated
165,00 US$
+13,6%
11/16/2026
Lu Li
Bank of America Securities
Hold
Reiterated
185,00 US$
+27,4%
11/16/2026
Luke Sergott
Barclays
Hold
Maintained
175,00 US$
+20,5%
11/16/2026
Paul Knight
KeyBanc
Buy
Reiterated
200,00 US$
+37,7%
11/16/2026
Dan Leonard
RBC Capital
Hold
Maintained
172,00 US$
+18,4%
11/13/2026
Daniel Brennan
TD Cowen
Buy
Maintained
185,00 US$
+27,4%
11/04/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
190,00 US$
+30,8%
11/04/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
180,00 US$
+23,9%
11/03/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
165,00 US$
+13,6%
10/09/2026
Matt Larew
William Blair
Buy
Initiated
-
-
10/05/2026
Evie Koslosky
Goldman Sachs
Hold
Maintained
140,00 US$
-3,6%
09/20/2026
Unknown Analyst
CFRA
Hold
Downgraded
-
-
09/18/2026
Unknown Analyst
UBS
Hold
Initiated
140,00 US$
-3,6%
09/08/2026
Doug Schenkel
UBS
Hold
Downgraded
140,00 US$
-3,6%
09/09/2026
Unknown Analyst
KeyBanc
Buy
Maintained
165,00 US$
+13,6%
09/04/2026
Evan Stampler
Wells Fargo
Hold
Maintained
110,00 US$
-24,3%
08/05/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
110,00 US$
-24,3%
08/05/2026
Michael Polark
Wolfe Research
Hold
Initiated
-
-
06/01/2026
Unknown Analyst
Guggenheim
Hold
Reiterated
-
-
05/11/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
95,00 US$
-34,6%
04/14/2026
Jack Meehan
Nephron
Hold
Upgraded
90,00 US$
-38%
03/26/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
110,00 US$
-24,3%
02/03/2026
Tycho Peterson
Jefferies
Hold
Maintained
105,00 US$
-27,7%
02/02/2026
Oxirgi hisobot
3-noy, 2026
Moliya davri
Ch.3 2026
1,37 US$ / 1,30 US$
+5,68%musbat
Taxminiy daromad (USD)
728,90 mln / 694,74 mln
+4,92%musbat
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
dek, 2025
apr, 2026
iyl, 2026
okt, 2026
Daromad
772,06 mln
711,12 mln
729,69 mln
728,90 mln
Sotilgan mahsulotning tannarxi
350,40 mln
323,46 mln
312,82 mln
310,32 mln
Daromad narxi
350,40 mln
323,46 mln
312,82 mln
310,32 mln
Tadqiqot va ishlanmalarga xarajatlar
58,18 mln
57,89 mln
48,97 mln
48,11 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
208,55 mln
241,91 mln
243,46 mln
247,53 mln
Operatsion xarajatlar
266,73 mln
299,80 mln
292,43 mln
295,64 mln
Jami operatsion xarajatlar
617,12 mln
623,26 mln
605,25 mln
605,96 mln
Operatsion daromad
154,93 mln
87,86 mln
124,44 mln
122,94 mln
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
91,56 mln
49,99 mln
63,53 mln
77,68 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
133,38 mln
65,92 mln
105,36 mln
105,30 mln
Daromad soligʻi boʻyicha xarajat
-4,21 mln
9,10 mln
10,05 mln
15,06 mln
Amaldagi soliq stavkasi
-4,60%
18,20%
15,82%
19,39%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
98,36 mln
40,72 mln
51,82 mln
62,30 mln
Sof foyda marjasi
12,74%
5,73%
7,10%
8,55%
Har bir aksiya foydasi
1,70
1,06
1,41
1,37
Foizlar va investitsiyalardan olingan daromadlar
5,75 mln
6,30 mln
5,26 mln
3,54 mln
Foizlarni toʻlash xarajatlari
-23,51 mln
-24,72 mln
-22,99 mln
-20,81 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-17,76 mln
-18,41 mln
-17,73 mln
-17,27 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
258,01 mln
192,91 mln
226,47 mln
225,86 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-5,07 mln
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
Kelgusi tadbirlar
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari